{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:35:15Z","timestamp":1778855715305,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Italian Ministry of Health- Ricerca Corrente"},{"name":"University of Milan - Linea 2"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04113-7","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T08:41:52Z","timestamp":1732783312000},"page":"1246-1256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aberrant promoter methylation, expression and function of RASSF1A gene in a series of Italian parathyroid tumors"],"prefix":"10.1007","volume":"87","author":[{"given":"Chiara","family":"Verdelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico Pio","family":"Fabrizio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Maroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Morotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia Stefania","family":"Tavanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Carrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Guarnieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena","family":"Cetani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Perticone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Vaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia Anna","family":"Muscarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8140-3175","authenticated-orcid":false,"given":"Sabrina","family":"Corbetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"4113_CR1","doi-asserted-by":"publisher","first-page":"12633","DOI":"10.18632\/oncotarget.7279","volume":"7","author":"Z Yuan","year":"2016","unstructured":"Z. Yuan, C. S\u00e1nchez Claros, M. Suzuki, E.C. Maggi, J.D. Kaner, N. Kinstlinger, J. Gorecka, T.J. Quinn, R. Geha, A. Corn, J. Pastoriza, Q. Jing, A. Adem, H. Wu, G. Alemu, Y.-C. Du, D. Zheng, J.M. Greally, S.K. Libutti, Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis. Oncotarget 7, 12633\u201312650 (2016). https:\/\/doi.org\/10.18632\/oncotarget.7279","journal-title":"Oncotarget"},{"key":"4113_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13148-016-0197-2","volume":"8","author":"E Barazeghi","year":"2016","unstructured":"E. Barazeghi, A.J. Gill, S. Sidhu, O. Norl\u00e9n, R. Dina, F.F. Palazzo, P. Hellman, P. St\u00e5lberg, G. Westin, 5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma. Clin. Epigenet. 8, 31 (2016). https:\/\/doi.org\/10.1186\/s13148-016-0197-2","journal-title":"Clin. Epigenet."},{"key":"4113_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3390\/cancers11070959","volume":"11","author":"G Malpeli","year":"2019","unstructured":"G. Malpeli, G. Innamorati, I. Decimo, M. Bencivenga, A.H. Nwabo Kamdje, R. Perris, C. Bassi, Methylation dynamics of RASSF1A and its impact on cancer. Cancers 11, 959 (2019). https:\/\/doi.org\/10.3390\/cancers11070959","journal-title":"Cancers"},{"key":"4113_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.mce.2017.05.010","volume":"469","author":"V Guarnieri","year":"2018","unstructured":"V. Guarnieri, L.A. Muscarella, C. Verdelli, S. Corbetta, Alterations of DNA methylation in parathyroid tumors. Mol. Cell. Endocrinol. 469, 60\u201369 (2018). https:\/\/doi.org\/10.1016\/j.mce.2017.05.010","journal-title":"Mol. Cell. Endocrinol."},{"key":"4113_CR5","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1038\/onc.2011.372","volume":"31","author":"C Chow","year":"2012","unstructured":"C. Chow, N. Wong, M. Pagano, S.W. Lun, K.I. Nakayama, K. Nakayama, K.W. Lo, Regulation of APC\/CCdc20 activity by RASSF1A-APC\/CCdc20 circuitry. Oncogene 31, 1975\u20131987 (2012). https:\/\/doi.org\/10.1038\/onc.2011.372","journal-title":"Oncogene"},{"key":"4113_CR6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1158\/0008-5472.CAN-06-2530","volume":"67","author":"E Estrabaud","year":"2007","unstructured":"E. Estrabaud, I. Lassot, G. Blot, E. Le Rouzic, V. Tanchou, E. Quemeneur, L. Daviet, F. Margottin-Goguet, R. Benarous, RASSF1C, an isoform of the tumor suppressor RASSF1A, promotes the accumulation of beta-catenin by interacting with betaTrCP. Cancer. Res. 67, 1054\u20131061 (2007). https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-2530","journal-title":"Cancer. Res."},{"key":"4113_CR7","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1007\/s13277-015-4660-z","volume":"37","author":"WG Wang","year":"2016","unstructured":"W.G. Wang, S.J. Chen, J.S. He, J.S. Li, X.F. Zang, The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway. Tumour. Biol. 37, 8869\u20138877 (2016). https:\/\/doi.org\/10.1007\/s13277-015-4660-z","journal-title":"Tumour. Biol."},{"key":"4113_CR8","unstructured":"WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours. Lyon, France: International Agency for Research on Cancer, 2022."},{"key":"4113_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/biomedicines9060637","volume":"9","author":"C Verdelli","year":"2021","unstructured":"C. Verdelli, A. Morotti, G.S. Tavanti, R. Silipigni, S. Guerneri, S. Ferrero, L. Vicentini, V. Vaira, S. Corbetta, The core stem genes SOX2, POU5F1\/OCT4, and NANOG are expressed in human parathyroid tumors and modulated by MEN1, YAP1, and \u03b2-catenin pathways activation. Biomedicines 9, 637 (2021). https:\/\/doi.org\/10.3390\/biomedicines9060637","journal-title":"Biomedicines"},{"key":"4113_CR10","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","volume":"37","author":"JP Bilezikian","year":"2022","unstructured":"J.P. Bilezikian, A.A. Khan, S.J. Silverberg, G.E. Fuleihan, C. Marcocci, S. Minisola, N. Perrier, A. Sitges-Serra, R.V. Thakker, G. Guyatt, M. Mannstadt, J.T. Potts, B.L. Clarke, M.L. Brandi, International Workshop on Primary Hyperparathyroidism.: Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the Fifth International Workshop. J. Bone Miner. Res. 37, 2293\u20132314 (2022). https:\/\/doi.org\/10.1002\/jbmr.4677","journal-title":"J. Bone Miner. Res."},{"key":"4113_CR11","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3390\/cancers11111691","volume":"11","author":"LA Muscarella","year":"2019","unstructured":"L.A. Muscarella, F.P. Fabrizio, M. De Bonis, M.T. Mancini, T. Balsamo, P. Graziano, F. Centra, A. Sparaneo, D. Trombetta, A. Bonfitto, V. Scagliusi, P. Larizza, E.D. Capoluongo, V.M. Fazio, Automated workflow for somatic and germline next generation sequencing analysis in routine clinical cancer diagnostics. Cancers 11, 1691 (2019). https:\/\/doi.org\/10.3390\/cancers11111691","journal-title":"Cancers"},{"key":"4113_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.5301\/JBM.2012.9766","volume":"27","author":"A La Torre","year":"2012","unstructured":"A. La Torre, L.A. Muscarella, P. Parrella, T. Balsamo, M. Bisceglia, V.M. Valori, A. La Torre, R. Barbano, E. Perrella, M.L. Poeta, G. Melchionda, G. Merla, E. Maiello, R. Pellicano, V.M. Fazio, Aberrant genes promoter methylation in neural crest-derived tumors. Int. J. Biol. Markers. 27, 389\u2013394 (2012). https:\/\/doi.org\/10.5301\/JBM.2012.9766","journal-title":"Int. J. Biol. Markers."},{"key":"4113_CR13","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.3390\/ijms20112697","volume":"20","author":"FP Fabrizio","year":"2019","unstructured":"F.P. Fabrizio, A. Sparaneo, F. Centra, D. Trombetta, C.T. Storlazzi, P. Graziano, E. Maiello, V.M. Fazio, L.A. Muscarella, Methylation density pattern of KEAP1 gene in lung cancer cell lines detected by quantitative methylation specific PCR and pyrosequencing. Int. J. Mol. Sci. 20, 2697 (2019). https:\/\/doi.org\/10.3390\/ijms20112697","journal-title":"Int. J. Mol. Sci."},{"key":"4113_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1530\/JME-16-0184","volume":"58","author":"A Mingione","year":"2017","unstructured":"A. Mingione, C. Verdelli, S. Ferrero, V. Vaira, V. Guarnieri, A. Scillitani, L. Vicentini, G. Balza, E. Beretta, A. Terranegra, G. Vezzoli, L. Soldati, S. Corbetta, Filamin A is reduced and contributes to the CASR sensitivity in human parathyroid tumors. J. Mol. Endocrinol. 58, 91\u2013103 (2017). https:\/\/doi.org\/10.1530\/JME-16-0184","journal-title":"J. Mol. Endocrinol."},{"key":"4113_CR15","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.3390\/ijms22042016","volume":"22","author":"GS Tavanti","year":"2021","unstructured":"G.S. Tavanti, C. Verdelli, A. Morotti, P. Maroni, V. Guarnieri, A. Scillitani, R. Silipigni, S. Guerneri, R. Maggiore, G. Mari, L. Vicentini, P. Dalino Ciaramella, V. Vaira, S. Corbetta, Yes-Associated Protein 1 is a novel Calcium Sensing Receptor target in human parathyroid tumors. Int. J. Mol. Sci. 22, 2016 (2021). https:\/\/doi.org\/10.3390\/ijms22042016","journal-title":"Int. J. Mol. Sci."},{"key":"4113_CR16","doi-asserted-by":"publisher","first-page":"59301","DOI":"10.18632\/oncotarget.19573","volume":"8","author":"Q Lai","year":"2017","unstructured":"Q. Lai, Y.H. Xu, Q. Chen, L. Tang, A.G. Li, L.F. Zhang, C.F. Zhang, J.F. Song, Z.Z. Du, The loss-of-function of DNA methyltransferase 1 by siRNA impairs the growth of non-small cell lung cancer with alleviated side effects via reactivation of RASSF1A and APC in vitro and vivo. Oncotarget 8, 59301\u201359311 (2017). https:\/\/doi.org\/10.18632\/oncotarget.19573","journal-title":"Oncotarget"},{"key":"4113_CR17","doi-asserted-by":"publisher","first-page":"e1003705","DOI":"10.1371\/journal.pgen.1003705","volume":"9","author":"FC Beckedorff","year":"2013","unstructured":"F.C. Beckedorff, A.C. Ayupe, R. Crocci-Souza, M.S. Amaral, H.I. Nakaya, D.T. Soltys, C.F. Menck, E.M. Reis, S. Verjovski-Almeida, The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. PLoS. Genet. 9, e1003705 (2013). https:\/\/doi.org\/10.1371\/journal.pgen.1003705","journal-title":"PLoS. Genet."},{"key":"4113_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12022-010-9121-z","volume":"21","author":"CC Juhlin","year":"2010","unstructured":"C.C. Juhlin, I.L. Nilsson, K. Johansson, F. Haglund, A. Villablanca, A. H\u00f6\u00f6g, C. Larsson, Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas. Endocr. Pathol. 21, 166\u2013177 (2010). https:\/\/doi.org\/10.1007\/s12022-010-9121-z","journal-title":"Endocr. Pathol."},{"key":"4113_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03143-8","volume":"7","author":"AK Arya","year":"2017","unstructured":"A.K. Arya, S.K. Bhadada, P. Singh, N. Sachdeva, U.N. Saikia, D. Dahiya, A. Behera, A. Bhansali, S.D. Rao, Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas. Sci. Rep. 7, 3123 (2017). https:\/\/doi.org\/10.1038\/s41598-017-03143-8","journal-title":"Sci. Rep."},{"key":"4113_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/15592294.2019.1615355","volume":"14","author":"N Calanca","year":"2019","unstructured":"N. Calanca, A.P. Paschoal, \u00c9.P. Munhoz, L.T. Galindo, B.M. Barbosa, J.R.F. Caldeira, R.A. Oliveira, L.R. Cavalli, S.R. Rogatto, C.A. Rainho, The long non-coding RNA ANRASSF1 in the regulation of alternative protein-coding transcripts RASSF1A and RASSF1C in human breast cancer cells: implications to epigenetic therapy. Epigenetics 14, 741\u2013750 (2019). https:\/\/doi.org\/10.1080\/15592294.2019.1615355","journal-title":"Epigenetics"},{"key":"4113_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/gcc.20895","volume":"50","author":"LF Starker","year":"2011","unstructured":"L.F. Starker, J. Svedlund, R. Udelsman, H. Dralle, G. Akerstr\u00f6m, G. Westin, R.P. Lifton, P. Bj\u00f6rklund, T. Carling, The DNA methylome of benign and malignant parathyroid tumors. Genes Chromosomes Cancer 50, 735\u2013745 (2011). https:\/\/doi.org\/10.1002\/gcc.20895","journal-title":"Genes Chromosomes Cancer"},{"key":"4113_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.4161\/epi.24823","volume":"8","author":"L Sulaiman","year":"2013","unstructured":"L. Sulaiman, C.C. Juhlin, I.L. Nilsson, O. Fotouhi, C. Larsson, J. Hashemi, Global and gene-specific promoter methylation analysis in primary hyperparathyroidism. Epigenetics 8, 646\u2013655 (2013). https:\/\/doi.org\/10.4161\/epi.24823","journal-title":"Epigenetics"},{"key":"4113_CR23","doi-asserted-by":"publisher","first-page":"e9472","DOI":"10.1371\/journal.pone.0009472","volume":"5","author":"CC Juhlin","year":"2010","unstructured":"C.C. Juhlin, N.B. Kiss, A. Villablanca, F. Haglund, J. Nordenstr\u00f6m, A. H\u00f6\u00f6g, C. Larsson, Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours. PLoS One 5, e9472 (2010). https:\/\/doi.org\/10.1371\/journal.pone.0009472","journal-title":"PLoS One"},{"key":"4113_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-294","volume":"9","author":"J Svedlund","year":"2010","unstructured":"J. Svedlund, M. Aur\u00e9n, M. Sundstr\u00f6m, H. Dralle, G. Akerstr\u00f6m, P. Bj\u00f6rklund, G. Westin, Aberrant WNT\/\u03b2-catenin signaling in parathyroid carcinoma. Mol. Cancer. 9, 294 (2010). https:\/\/doi.org\/10.1186\/1476-4598-9-294","journal-title":"Mol. Cancer."},{"key":"4113_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/cancers12010229","volume":"12","author":"L Garc\u00eda-Guti\u00e9rrez","year":"2020","unstructured":"L. Garc\u00eda-Guti\u00e9rrez, S. McKenna, W. Kolch, D. Matallanas, RASSF1A tumour suppressor: target the network for effective cancer therapy. Cancers 12, 229 (2020). https:\/\/doi.org\/10.3390\/cancers12010229","journal-title":"Cancers"},{"key":"4113_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.clinre.2013.11.004","volume":"38","author":"J Xiang","year":"2014","unstructured":"J. Xiang, F. Luo, Y. Chen, F. Zhu, J. Wang, si-DNMT1 restore tumor suppressor genes expression through the reversal of DNA hypermethylation in cholangiocarcinoma. Clin. Res. Hepatol. Gastroenterol. 38, 181\u2013189 (2014). https:\/\/doi.org\/10.1016\/j.clinre.2013.11.004","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"4113_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12957-015-0557-y","volume":"13","author":"Z Du","year":"2015","unstructured":"Z. Du, K. Ma, X. Sun, A. Li, H. Wang, L. Zhang, F. Lin, X. Feng, J. Song, Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma. World J. Surg. Oncol. 13, 141 (2015). https:\/\/doi.org\/10.1186\/s12957-015-0557-y","journal-title":"World J. Surg. Oncol."},{"key":"4113_CR28","doi-asserted-by":"publisher","first-page":"44129","DOI":"10.18632\/oncotarget.9866","volume":"7","author":"J Bai","year":"2016","unstructured":"J. Bai, X. Zhang, K. Hu, B. Liu, H. Wang, A. Li, F. Lin, L. Zhang, X. Sun, Z. Du, J. Song, Silencing DNA methyltransferase 1 (DNMT1) inhibits proliferation, metastasis and invasion in ESCC by suppressing methylation of RASSF1A and DAPK. Oncotarget 7, 44129\u201344141 (2016). https:\/\/doi.org\/10.18632\/oncotarget.9866","journal-title":"Oncotarget"},{"key":"4113_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.30699\/ijp.2019.94401.1922","volume":"14","author":"F Khatami","year":"2019","unstructured":"F. Khatami, B. Larijani, R. Heshmat, S. Nasiri, H. Saffar, G. Shafiee, A. Mossafa, S.M. Tavangar, Promoter methylation of four tumor suppressor genes in human papillary thyroid carcinoma. Iran. J. Pathol. 14, 290\u2013298 (2019). https:\/\/doi.org\/10.30699\/ijp.2019.94401.1922","journal-title":"Iran. J. Pathol."},{"key":"4113_CR30","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.12659\/MSM.910608","volume":"24","author":"HS Ma","year":"2018","unstructured":"H.S. Ma, E.L. Wang, W.F. Xu, S. Yamada, K. Yoshimoto, Z.R. Qian, L. Shi, L.L. Liu, X.H. Li, Overexpression of DNA (cytosine-5)-methyltransferase 1 (DNMT1) and DNA (cytosine-5)-methyltransferase 3A (DNMT3A) is associated with aggressive behavior and hypermethylation of tumor suppressor genes in human pituitary adenomas. Med. Sci. Monit. 24, 4841\u20134850 (2018). https:\/\/doi.org\/10.12659\/MSM.910608","journal-title":"Med. Sci. Monit."},{"key":"4113_CR31","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1002\/jbmr.4154","volume":"35","author":"A Morotti","year":"2020","unstructured":"A. Morotti, I. Forno, C. Verdelli, V. Guarnieri, F. Cetani, A. Terrasi, R. Silipigni, S. Guerneri, V. Andr\u00e8, A. Scillitani, L. Vicentini, S. Ferrero, S. Corbetta, V. Vaira, The oncosuppressors MEN1 and CDC73 are involved in lncRNA deregulation in human parathyroid tumors. J. Bone Miner. Res. 35, 2423\u20132431 (2020). https:\/\/doi.org\/10.1002\/jbmr.4154","journal-title":"J. Bone Miner. Res."},{"key":"4113_CR32","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1210\/jcem.87.5.8492","volume":"87","author":"S Corbetta","year":"2002","unstructured":"S. Corbetta, A. Lania, M. Filopanti, L. Vicentini, E. Ballar\u00e9, A. Spada, Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells. J. Clin. Endocrinol. Metab. 87, 2201\u20132205 (2002). https:\/\/doi.org\/10.1210\/jcem.87.5.8492","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4113_CR33","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1210\/jc.2002-021427","volume":"88","author":"O Kifor","year":"2003","unstructured":"O. Kifor, I. Kifor, F.D. Moore Jr., R.R. Butters Jr., T. Cantor, P. Gao, E.M. Brown, Decreased expression of caveolin-1 and altered regulation of mitogen-activated protein kinase in cultured bovine parathyroid cells and human parathyroid adenomas. J. Clin. Endocrinol. Metab. 88, 4455\u20134464 (2003). https:\/\/doi.org\/10.1210\/jc.2002-021427","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4113_CR34","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1128\/MCB.01506-13","volume":"34","author":"RR Ram","year":"2014","unstructured":"R.R. Ram, S. Mendiratta, B.O. Bodemann, M.J. Torres, U. Eskiocak, M.A. White, RASSF1A inactivation unleashes a tumor suppressor\/oncogene cascade with context-dependent consequences on cell cycle progression. Mol. Cell. Biol. 34, 2350\u20132358 (2014). https:\/\/doi.org\/10.1128\/MCB.01506-13","journal-title":"Mol. Cell. Biol."},{"key":"4113_CR35","first-page":"577","volume":"11","author":"F Nan","year":"2018","unstructured":"F. Nan, S. Wei, D. Guan, L. Zhang, Q. Guo, S. Cao, Y. Liu, Y. Liu, M. Sun, Suppressive efficiency of RASSF1A in endometrial carcinoma via inhabiting estrogen receptor alpha expression and ERK pathway activation. Int. J. Clin. Exp. Pathol. 11, 577\u2013585 (2018). PMC6958056","journal-title":"Int. J. Clin. Exp. Pathol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04113-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04113-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04113-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:22:27Z","timestamp":1740129747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04113-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["4113"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04113-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5256882\/v1","asserted-by":"object"}]},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"13 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of Ospedale San Raffaele Ethical Committee in Milan, Italy (protocol code CE40\/2019 GPRC6A PARA, approved on 07\/03\/2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent Statement"}}]}}